ClinicalTrials.Veeva

Menu

Point of Care Testing for Advanced Practitioners (Paramedics) (POCTPara)

Y

Yorkshire Ambulance Service NHS Trust

Status

Unknown

Conditions

Point of Care Testing
Allied Health Professional
Clinical Decision-Making
Community Urgent & Emergency Care

Treatments

Device: Interventional Diagnostic Device Arm
Other: Usual care

Study type

Interventional

Funder types

Other

Identifiers

NCT05054049
YASRD148

Details and patient eligibility

About

Point of care testing (POCT) is described as a laboratory test conducted near the patient with a rapid result obtained through a portable analysing device, as opposed to the collection of a blood sample being transferred to a central laboratory for analysis and reporting.

Over the past 15 years increasing emphasis has been placed upon the paramedic profession as a possible solution to addressing the increasing demands placed on emergency departments. This is largely viewed through the ability of paramedics to assess patients calling 999 and manage a patient's condition away from the emergency department, with sufficient evidence supporting the role of the paramedic to develop competencies to manage larger volumes of patients.

This feasibility study will seek to understand whether paramedics report that the use of POCT devices is useful in safe clinical decision making with patients in the community, and if it is possible to use the Abbott i-STAT device in the urgent and emergency care setting for those patients where management within the community is being considered.

Given that there is very little evidence in this subject area, the research should start to inform the potential for future innovations in paramedic and community practice, and build on the body of evidence regarding POCT by paramedics related to community management.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Paramedic Participants

Inclusion criteria:

  • HCPC registered paramedics employed as advanced practitioners
  • From the selected advanced practitioner team (Sheffield)
  • Able to provide informed consent
  • Willing to undergo training and to deliver intervention
  • Willing to undergo training to participate in study measures and processes
  • Willing to take part in the focus group

Patient Participants

Inclusion criteria:

  • Adult patients aged 18 years old and over.
  • Registered with a GP Surgery in the Sheffield CCG boundary.
  • In their normal home environment, care home, nursing home or step up intermediate bed service, experiencing an ambulatory sensitive presentation related to falls, frailty, mild to moderate breathlessness, or non-specific general illness and receiving an ambulance service response from participating advanced practitioners (paramedics).
  • Who do not require immediate life-saving intervention/immediate transfer to ED.
  • Able to give written consent during the call-out.

Exclusion criteria

Paramedic Participants:

• Any HCPC registered advanced practitioner (paramedic) who is currently under investigation for fitness to practice.

Patient Participants

  • Patients requiring emergency intervention and immediate transfer to hospital.
  • Patient does not have mental capacity.
  • Clinical presentations that should not have any delayed on scene time, meeting the criteria outlined in the YAS policy for the assessment, conveyance and referral of patients, for example detailing the NEWS2 score and other appropriate clinical screening tools that assist in the decision making regarding the decision to convey or refer for community management.
  • Non-English speaking patients.
  • End of life care patients.
  • Patients residing in prison.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups, including a placebo group

Abbott i-stat Allinity
Experimental group
Description:
Randomised patients to this arm receive the application of the point of care testing device to provide further diagnostic information to assist clinical decision making.
Treatment:
Device: Interventional Diagnostic Device Arm
Usual Care
Placebo Comparator group
Description:
Randomised patients to this arm receive usual care.
Treatment:
Other: Usual care

Trial contacts and locations

0

Loading...

Central trial contact

Andrew Hodge; Bryan Lightowler

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems